________________________________________________

1. Amer A, Fischer H, Li X. The natural history of pityriasisrosea in black American children: how correct is the «classic» description? Arch Pediatr Adolesc Med 2007; 161 (5): 503–6.
2. Arndt KA, Paul BS, Stern RS, Parrish JA. Treatment of pityriasisrosea with UV radiation. Arch Dermatol 1983; 119 (5): 381–2.
3. Ackerman AB. Pityriasisrosea. Histiologic Diagnosis of Inflammatory Skin Disease: 
A Method by Pattern Analysis. Philadelphia, Pa: Lea & Febiger 1978.
4. Bjornberg A, Hellgren L. Pityriasisrosea. 
A statistical, clinical, and laboratory investigation of 826 patients and matched healthy controls. Acta Derm Venereol Suppl (Stockh) 1962; 42 (Suppl. 50): 1–68.
5. Bjornberg A, Tegner E. Pityriasisrosea. In: I.Freedberg, A.Eisen, K.Wolff et al, eds. Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill 1999: p. 541–6.
6. Broccolo F, Drago F, Careddu AM et al. Additional evidence that pityriasisrosea is associated with reactivation of human herpesvirus-6 and -7. J Invest Dermatol 2005; 124 (6): 1234–40.
7. Chuang TY, Ilstrup DM, Perry HO, Kurland LT. Pityriasisrosea in Rochester, Minnesota, 1969 to 1978. J Am Acad Dermatol 1982; 7 (1): 80–9.
8. Chuh AA, Chan PK, Lee A. The detection of human herpesvirus-8 DNA in plasma and peripheral blood mononuclear cells in adult patients with pityriasisrosea by polymerase chain reaction. J Eur Acad Dermatol Venereol 2006; 20 (6): 667–71.
9. Drago F, Broccolo F, Rebora A. Pityriasisrosea: an update with a critical appraisal of its possible herpesviral etiology. J Am Acad Dermatol 2009; 61 (2): 303–18.
10. Drago F, Broccolo F, Zaccaria E et al. Pregnancy outcome in patients with pityriasisrosea. J Am Acad Dermatol 2008; 58 (5 Suppl. 1): S78–83.
11. Drago F, Ranieri E, Malaguti F et al. Human herpesvirus 7 in patients with pityriasisrosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin. Dermatology 1997; 195 (4): 374–8.
12. Drago F, Vecchio F, Rebora A. Use of high-dose acyclovir in pityriasisrosea. J Am Acad Dermatol 2006; 54 (1): 82–5.
13. Leenutaphong V, Jiamton S. UVB phototherapy for pityriasisrosea: a bilateral comparison study. J Am Acad Dermatol 1995; 33 (6): 996–9.
14. Miljkovic J, Bercic M, Belic M. Pityriasisrosea with unusual papulovesicular presentation. Acta Derm Venerol 1996; 5: 61–3.
15. Parsons JM. Pityriasisrosea update: 1986. J Am Acad Dermatol 1986; 15 (2 Pt 1): 159–67.
16. Rasi A, Tajziehchi L, Savabi-Nasab S. Oral erythromycin is ineffective in the treatment of pityriasisrosea. J Drugs Dermatol 2008; 7 (1): 35–8.
17. Sezer E, Saracoglu ZN, Urer SM et al. Purpuricpityriasisrosea. Int J Dermatol 2003; 42 (2): 138–40.
18. Toussant S, Kareino H. Pityriasisrosea. In: D.Elder, R.Elenitsas, C.Jaworsky et al, eds. Lever's Histopathology of the Skin. 8th ed. Philadelphia, Pa: Lippincott-Raven 1997: 164–5.